Linked Life Data

12718076

Source:http://linkedlifedata.com/resource/pubmed/id/12718076

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-4-29
pubmed:abstractText
A variety of methods are utilized to detect antiplatelet autoantibodies nowadays, platelet-associated immunoglobulin G(PAIgG) is a phase II assay of limited value in the meaning of its sensitivity and specificity for the diagnosis of idiopathic thrombocytopenic purpura(ITP), although it has been ordered in many occasions. The newer antigen-specific assays(phase III), which can identify autoantibodies against platelet glycoprotein(GP)s, such as GP IIb/IIIa, with greater specificity but lower sensitivity are rarely performed in clinical situations in Japan. Development of novel systems to detect clinically more relevant markers, including specific antiplatelet autoantibodies, is necessary for the diagnosis of ITP.
pubmed:language
jpn
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0047-1852
pubmed:author
pubmed:issnType
Print
pubmed:volume
61
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
564-8
pubmed:dateRevised
2011-7-27
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
[The detection methods for antiplatelet autoantibodies (phase II and phase III assay)].
pubmed:affiliation
Second Department of Internal Medicine, Shinshu University School of Medicine.
pubmed:publicationType
Journal Article, English Abstract, Review